Theodorou M, Tsiantou V, Pavlakis A, Maniadakis N, Fragoulakis V, Pavi E, et al. Factors influencing prescribing behaviour of physicians in Greece and Cyprus: results from a questionnaire based survey. BMC Health Serv Res. 2009;9:150. doi:10.1186/1472-6963-9-150.
PubMed Central
PubMed
Article
Google Scholar
Tsiantou V, Zavras D, Kousoulakou H, Geitona M, Kyriopoulos J. Generic medicines: Greek physicians’ perceptions and prescribing practices. J Clin Pharm Ther. 2009;34(5):547–54. doi:10.1111/j.1365-2710.2009.01037.x.
CAS
PubMed
Article
Google Scholar
Liberman JN, Roebuck MC. Prescription drug costs and the generic dispensing ratio. J Manag Care Pharm. 2010;16(7):502–6.
PubMed
Google Scholar
US Food and Drug Administration Centre for Drug Evaluation and Research Office of Generic Drugs. Abbreviated New Drug Application (ANDA): generics. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/default.htm. Accessed 21 Nov 2012.
Henney JE. Review of generic bioequivalence studies from the food and drug administration. JAMA. 1999;282(21):1995. doi:10.1001/jama.282.21.1995-JFD90010-2-1.
CAS
PubMed
Article
Google Scholar
Davit BM, Nwakama PE, Buehler GJ, Conner DP, Haidar SH, Patel DT, Yang Y, Yu LX, Woodcock J. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the FDA. Ann Pharmacother. 2009;43(10):1583–97. doi:10.1345/aph.1M141. Epub 23 Sept 2009.
McLachlan AJ. Generic medicines literacy—minimising the potential for patient confusion [Editorial]. Med J Aust. 2010;192(7):368–9.
PubMed
Google Scholar
Ramzan I. Bioavailability, bioequivalence, generics and switching or substitution: science, emotion and vested interests [Letter]. J Pharm Pract Res. 2010;40(2):90–1.
Peterson GM. Generic substitution: a need for clarification. Br J Clin Pharmacol. 2011;71(6):966–7. doi:10.1111/j.1365-2125.2010.03872.x.
PubMed Central
PubMed
Article
Google Scholar
US Food and Drug Administration Centre for Drug Evaluation and Research Office of Generic Drugs. Orange book preface. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/ucm079068.htm. Accessed 21 Nov 2012.
European Parliament, Council of the European Union: Directive 2001/83/EC of 6 November 2001 on the Community code relating to medicinal products for human use. OJ L 311, 11/28/2001, latest consolidated version: 02001L0083-20121116. Off J Eur Commun. 2011;(L311):67–128.
North Carolina Board of Pharmacy. http://www.ncbop.org. Accessed 10 Dec 2012.
Andermann F, Duh MS, Gosselin A, Paradis PE. Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes. Epilepsia. 2007;48(3):464–9. doi:10.1111/j.1528-1167.2007.01007.x.
CAS
PubMed
Article
Google Scholar
Duh MS, Paradis PE, Latremouille-Viau D, Greenberg PE, Lee SP, Durkin MB, et al. The risks and costs of multiple-generic substitution of topiramate. Neurology. 2009;72(24):2122–9. doi:10.1212/WNL.0b013e3181aa5300.
CAS
PubMed
Article
Google Scholar
Ringe JD, Moller G. Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis. Rheumatol Int. 2009;30(2):213–21. doi:10.1007/s00296-009-0940-5.
CAS
PubMed
Article
Google Scholar
Duh MS, Cahill KE, Paradis PE, Cremieux PY, Greenberg PE. The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence. Expert Opin Pharmacother. 2009;10(14):2317–28. doi:10.1517/14656560903140525.
CAS
PubMed
Article
Google Scholar
Desmarais JE, Beauclair L, Margolese HC. Switching from brand-name to generic psychotropic medications: a literature review. CNS Neurosci Ther. 2011;17(6):750–60. doi:10.1111/j.1755-5949.2010.00210.x.
PubMed
Article
Google Scholar
Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart MA, Choudhry NK, et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA. 2008;300(21):2514–26. doi:10.1001/jama.2008.758.
CAS
PubMed Central
PubMed
Article
Google Scholar
Kesselheim AS, Stedman MR, Bubrick EJ, Gagne JJ, Misono AS, Lee JL, et al. Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis. Drugs. 2010;70(5):605–21. doi:10.2165/10898530-000000000-00000.
CAS
PubMed Central
PubMed
Article
Google Scholar
Alessi-Severini S, Honcharik PL, Simpson KD, Eleff MK, Collins DM. Evaluation of an interchangeability switch in patients treated with clozapine: A retrospective review. J Clin Psychiatry. 2006;67(7):1047–54.
CAS
PubMed
Article
Google Scholar
Amit G, Rosen A, Wagshal AB, Bonneh DY, Liss T, Grosbard A, Ilia R, Katz A. Efficacy of substituting innovator propafenone for its generic formulation in patients with atrial fibrillation. Am J Cardiol. 2004;93(12):1558–60.
CAS
PubMed
Article
Google Scholar
Andermann F, Duh MS, Gosselin A, Paradis PE. Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes. Epilepsia. 2007;48(3):464–9.
CAS
PubMed
Article
Google Scholar
Araszkiewicz AA, Szabert K, Godman B, Wladysiuk M, Barbui C, Haycox A. Generic olanzapine: health authority opportunity or nightmare? Expert Rev Pharmacoeconomics Outcomes Res. 2008;8(6):549–55.
Article
Google Scholar
Assawawitoontip S, Wiwanitkit V. A randomized crossover study to evaluate LDL-cholesterol lowering effect of a generic product of simvastatin (Unison Company) compared to simvastatin (Zocor) in hypercholesterolemic subjects. J Med Assoc Thail. 2002;85(Suppl 1):S118–24.
Google Scholar
Boh M, Opolski G, Poredos P, Ceska R, Jezovnik M. Therapeutic equivalence of the generic and the reference atorvastatin in patients with increased coronary risk. Int Angiol. 2011;30(4):366–74.
CAS
PubMed
Google Scholar
Burkhardt RT, Leppik IE, Blesi K, Scott S, Gapany SR, Cloyd JC. Lower phenytoin serum levels in persons switched from brand to generic phenytoin. Neurology. 2004;63(8):1494–6.
CAS
PubMed
Article
Google Scholar
Carius A, Schulze-Bonhage A. Changing lamotrigine preparations in epilepsy patients. Experiences of a university epilepsy outpatient centre. Nervenarzt. 2010;81(4):423–34.
CAS
PubMed
Article
Google Scholar
Chaluvadi S, Chiang S, Tran L, Goldsmith CE, Friedman DE. Clinical experience with generic levetiracetam in people with epilepsy. Epilepsia. 2011;52(4):810–5.
CAS
PubMed Central
PubMed
Article
Google Scholar
Diarra DA, Riegersperger M, Saemann MD, Sunder-Plassmann G. Maintenance immunosuppressive therapy and generic cyclosporine A use in adult renal transplantation: a single center analysis. Kidney Int Suppl. 2010;115:S8–11.
CAS
PubMed
Article
Google Scholar
Duh MS, Andermann F, Paradis PE, Weiner J, Manjunath R, Cremieux PY. The economic consequences of generic substitution for antiepileptic drugs in a public payer setting: the case of lamotrigine. Dis Manag. 2007;10(4):216–25.
PubMed
Article
Google Scholar
Duh MS, Paradis PE, Latremouille-Viau D, Greenberg PE, Lee SP, Durkin MB, Wan GJ, Rupnow MF, LeLorier J. The risks and costs of multiple-generic substitution of topiramate. Neurology. 2009;72(24):2122–9.
CAS
PubMed
Article
Google Scholar
Fujii H, Iihara H, Yasuda K, Matsuura K, Takahashi T, Yoshida K, Itoh Y. Evaluation of efficacy and safety of generic levofolinate in patients who received colorectal cancer chemotherapy. Med Oncol. 2011;28(2):488–93.
CAS
PubMed
Article
Google Scholar
Ghate SR, Biskupiak JE, Ye X, Hagan M, Kwong WJ, Fox ES, Brixner DI. Hemorrhagic and thrombotic events associated with generic substitution of warfarin in patients with atrial fibrillation: a retrospective analysis. Ann Pharmacother. 2011;45(6):701–12.
CAS
PubMed
Article
Google Scholar
Halkin H, Dushenat M, Silverman B, Shalev V, Loebstein R, Lomnicky Y, Friedman N. Brand versus generic alendronate: gastrointestinal effects measured by resource utilization. Ann Pharmacother. 2007;41(1):29–34.
CAS
PubMed
Article
Google Scholar
Halkin H, Shapiro J, Kurnik D, Loebstein R, Shalev V, Kokia E. Increased warfarin doses and decreased international normalized ratio response after nationwide generic switching. Clin Pharmacol Ther. 2003;74(3):215–21.
CAS
PubMed
Article
Google Scholar
Haroldson JA, Somerville KT, Carlson S, Hanson J, Emery RW, Lake KD. A retrospective assessment of safety, efficacy, and pharmacoeconomics of generic azathioprine in heart-transplant recipients. J Heart Lung Transplant. 2001;20(3):372–4.
CAS
PubMed
Article
Google Scholar
Hartung DM, Middleton L, Svoboda L, McGregor JC. Generic substitution of lamotrigine among medicaid patients with diverse indications: a cohort-crossover study. CNS Drugs. 2012;26(8):707–16.
CAS
PubMed Central
PubMed
Article
Google Scholar
Helderman JH, Kang N, Legorreta AP, Chen JY. Healthcare costs in renal transplant recipients using branded versus generic ciclosporin. Appl Health Econ Health Policy. 2010;8(1):61–8.
PubMed
Article
Google Scholar
Jeong YH, Koh JS, Kang MK, Ahn YJ, Kim IS, Park Y, Hwang SJ, Kwak CH, Hwang JY. The impact of generic clopidogrel bisulfate on platelet inhibition in patients with coronary artery stents: results of the ACCEL-GENERIC study. Korean J Intern Med. 2010;25(2):154–61.
CAS
PubMed Central
PubMed
Article
Google Scholar
Kim SH, Park K, Hong SJ, Cho YS, Sung JD, Moon GW, Yoon MH, Lee MY, Hyon MS, Kim DW, Kim HS. Efficacy and tolerability of a generic and a branded formulation of atorvastatin 20 mg/d in hypercholesterolemic Korean adults at high risk for cardiovascular disease: a multicenter, prospective, randomized, double-blind, double-dummy clinical trial. Clin Ther. 2010;32(11):1896–905.
CAS
PubMed
Article
Google Scholar
Kluznik JC, Walbek NH, Farnsworth MG, Melstrom K. Clinical effects of a randomized switch of patients from clozaril to generic clozapine. J Clin Psychiatry. 2001;62(Suppl 5):14-7. (Discussion 23-4).
Labiner DM, Paradis PE, Manjunath R, Duh MS, Lafeuille MH, Latremouille-Viau D, Lefebvre P, Helmers SL. Generic antiepileptic drugs and associated medical resource utilization in the United States. Neurology. 2010;74(20):1566–74.
CAS
PubMed
Article
Google Scholar
Lai PS, Chua SS, Chong YH, Chan SP. The effect of mandatory generic substitution on the safety of alendronate and patients’ adherence. Curr Med Res Opin. 2012;28(8):1347–55.
PubMed
Article
Google Scholar
Layton S, Barbeau M. Generic replacement of clozapine: a simple decision model from a Canadian perspective. Curr Med Res Opin. 2004;20(4):453–9.
PubMed
Article
Google Scholar
Lee HL, Kan CD, Yang YJ. Efficacy and tolerability of the switch from a branded to a generic warfarin sodium product: an observer-blinded, randomized, crossover study. Clin Ther. 2005;27(3):309–19.
CAS
PubMed
Article
Google Scholar
LeLorier J, Duh MS, Paradis PE, Latremouille-Viau D, Lefebvre P, Manjunath R, Sheehy O. Economic impact of generic substitution of lamotrigine: projected costs in the US using findings in a Canadian setting. Curr Med Res Opin. 2008;24(4):1069–81.
PubMed
Article
Google Scholar
LeLorier J, Duh MS, Paradis PE, Lefebvre P, Weiner J, Manjunath R, Sheehy O. Clinical consequences of generic substitution of lamotrigine for patients with epilepsy. Neurology. 2008;70(22 Pt 2):2179–86.
CAS
PubMed
Article
Google Scholar
McDevitt-Potter LM, Sadaka B, Tichy EM, Rogers CC, Gabardi S. A multicenter experience with generic tacrolimus conversion. Transplantation. 2011;92(6):653–7.
CAS
PubMed
Article
Google Scholar
Milligan PE, Banet GA, Waterman AD, Gatchel SK, Gage BF. Substitution of generic warfarin for Coumadin in an HMO setting. Ann Pharmacother. 2002;36(5):764–8.
PubMed
Article
Google Scholar
Momper JD, Ridenour TA, Schonder KS, Shapiro R, Humar A, Venkataramanan R. The impact of conversion from prograf to generic tacrolimus in liver and kidney transplant recipients with stable graft function. Am J Transplant. 2011;11(9):1861–7.
CAS
PubMed
Article
Google Scholar
Narayanaswamy A, Neog A, Baskaran M, George R, Lingam V, Desai C, Rajadhyaksha V. A randomized, crossover, open label pilot study to evaluate the efficacy and safety of Xalatan in comparison with generic Latanoprost (Latoprost) in subjects with primary open angle glaucoma or ocular hypertension. Indian J Ophthalmol. 2007;55(2):127–31.
PubMed
Article
Google Scholar
Pamugas GE, Danguilan RA, Lamban AB, Mangati VB, Ona ET. Safety and efficacy of generic cyclosporine arpimune in Filipino low-risk primary kidney transplant recipients. Transplant Proc. 2012;44(1):101–8.
CAS
PubMed
Article
Google Scholar
Ringe JD, Moller G. Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis. Rheumatol Int. 2009;30(2):213–21.
CAS
PubMed
Article
Google Scholar
Sajbel TA, Carter GW, Wiley RB. Converting patients from brand-name clozapine to generic clozapine. Ann Pharmacother. 2001;35(3):281–4.
CAS
PubMed
Article
Google Scholar
Ström O, Landfeldt E. The association between automatic generic substitution and treatment persistence with oral bisphosphonates. Osteoporos Int. 2012;23:2201–9.
Ude M, Schuessel K, Quinzler R, Leuner K, Muller WE, Schulz M. Generic switch after ramipril patent expiry is not associated with decreased pharmacy refill compliance: a retrospective study using the DAPI database. J Hypertens. 2011;29(9):1837–45.
CAS
PubMed
Article
Google Scholar
Van Wijk BL, Klungel OH, Heerdink ER, de Boer A. Generic substitution of antihypertensive drugs: does it affect adherence? Ann Pharmacother. 2006;40(1):15–20.
PubMed
Article
Google Scholar
Witt DM, Tillman DJ, Evans CM, Plotkin TV, Sadler MA. Evaluation of the clinical and economic impact of a brand name-to-generic warfarin sodium conversion program. Pharmacotherapy. 2003;23(3):360–8.
PubMed
Article
Google Scholar
Wiwanitkit V, Wangsaturaka D, Tangphao O. LDL-cholesterol lowering effect of a generic product of simvastatin compared to simvastatin (Zocor) in Thai hypercholesterolemic subjects—a randomized crossover study, the first report from Thailand. BMC Clin Pharmacol. 2002;2:1.
PubMed
Article
Google Scholar